Apheresis Equipment Market Share to Outstrip $3.85 Billion, Globally, by 2028 with 8% CAGR – Growth Report by The Insight Partners
09 févr. 2023 09h47 HE
|
The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Apheresis Equipment Market Size, Share, Revenue, Sales and Global Forecast to 2028 - Global Analysis by Product...
International Myeloma Foundation (IMF) Returns to In-Person Patient and Family Seminars in 2023, Announces Boca Raton Event
02 févr. 2023 08h45 HE
|
International Myeloma Foundation
BOCA RATON, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that this year’s first Patient and Family Seminar is taking place in-person and...
Veterinary Hematology Analyzers Market is expected to grow from USD 850 million in 2022 to USD 1515.9 million by 2030 : GreyViews
27 janv. 2023 16h00 HE
|
GreyViews
Pune India, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Provectus Biopharmaceuticals Releases 2023 Stockholder Letter
09 janv. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that it had issued a beginning-of-the-year letter for 2023 to the Company’s stockholders, which may be found...
Florida Cancer Specialists & Research Institute Research Breakthroughs Presented at Global Hematology Gathering
13 déc. 2022 09h17 HE
|
Florida Cancer Specialists & Research Institute
Fort Myers, Florida, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Research conducted at Florida Cancer Specialists & Research Institute, LLC (FCS) that is contributing to global advancements in the...
Aptose Announces Updated Clinical Responses, Breadth of Activity, and Safety Across Four Dose Levels of Tuspetinib in Difficult-to-Treat Acute Myeloid Leukemia Populations
11 déc. 2022 09h00 HE
|
Aptose Biosciences, Inc.
Company Provides Comprehensive Clinical Update from Phase 1/2 TrialTuspetinib Continues to Deliver Single Agent Responses in r/r AML PatientsTuspetinib Safety and Efficacy Profile may Position Drug to...
International Myeloma Foundation Named Winner of 2022 Amazon Web Services IMAGINE Grant for Nonprofits
01 déc. 2022 08h45 HE
|
International Myeloma Foundation
STUDIO CITY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced it has been selected as a winner of the 2022 Amazon Web Services (AWS) IMAGINE...
In-Vitro Diagnostics Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
15 nov. 2022 06h00 HE
|
Graphical Research
Pune, India, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The global in-vitro diagnostics market size is expected to witness remarkable growth during the forecast period, attributed to growing incidence of...
Aptose Treats First Patient with Continuous Dosing of New “G3” Formulation of Luxeptinib
14 nov. 2022 07h30 HE
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting...
Global Plasma Fractionation Market Envisioned to Generate a Revenue of $45,803.2 Million and Grow at a CAGR of 7.0% during the Forecast Period from 2020 to 2027 [165-Pages] | Published by Research DIve
29 août 2022 09h03 HE
|
Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global plasma fractionation market is anticipated to generate a revenue of $45,803.2 million...